Wednesday, December 11, 2013

Does America's Pill Epidemic Strengthen ELTP's Position For Investors?

Wouldn't long term investors like to know what the future holds for Elite Pharma?  Does the Affordable Care Act benefit from an abuse resistant drug? 

Is management really giving a fuck about investors?

Why didn't their latest PR, which stated ELTP was entering into human bio studies, shoot this baby to the North Pole?  In fact it's been all red since the drop...

Is December just a throwaway month for the market?

Who has the upper hand in the ongoing epic saga that is Tangerine vs. Dr. Lowenstein, lolol.

All these questions and the funniest ELTP fanatic name.   The votes are in and the funniest commentator name in all website threads is, by far, Gay Louis.

Good luck, investors!

No comments:

Post a Comment